Cargando…

ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2 × 2 factorial community randomized trial

BACKGROUND: TB and HIV form a deadly synergy in much of the developing world, especially Africa. Interventions to reduce the impact of these diseases at community level are urgently needed. This paper presents the design of a community randomised trial to evaluate the impact of two complex intervent...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayles, Helen M, Sismanidis, Charalambos, Beyers, Nulda, Hayes, Richard J, Godfrey-Faussett, Peter
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2585552/
https://www.ncbi.nlm.nih.gov/pubmed/18992133
http://dx.doi.org/10.1186/1745-6215-9-63
_version_ 1782160843615502336
author Ayles, Helen M
Sismanidis, Charalambos
Beyers, Nulda
Hayes, Richard J
Godfrey-Faussett, Peter
author_facet Ayles, Helen M
Sismanidis, Charalambos
Beyers, Nulda
Hayes, Richard J
Godfrey-Faussett, Peter
author_sort Ayles, Helen M
collection PubMed
description BACKGROUND: TB and HIV form a deadly synergy in much of the developing world, especially Africa. Interventions to reduce the impact of these diseases at community level are urgently needed. This paper presents the design of a community randomised trial to evaluate the impact of two complex interventions on the prevalence of tuberculosis (TB) in high HIV prevalence settings in Zambia and South Africa. METHODS: The interaction between TB and HIV is reviewed and possible interventions that could reduce the prevalence of TB in HIV-endemic populations are discussed. Two of these interventions are described in detail and the design of a 2 × 2 factorial community randomised trial to test these interventions is presented. The limitations and challenges of the design are identified and discussed. CONCLUSION: There is an urgent need to reduce the prevalence of TB in communities highly affected by HIV. Potential interventions are complex and require innovative trial designs to provide the rigorous evidence needed to inform health policy makers and to ensure that resources are used optimally. TRIAL REGISTRATION: Number: ISRCTN36729271
format Text
id pubmed-2585552
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25855522008-11-21 ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2 × 2 factorial community randomized trial Ayles, Helen M Sismanidis, Charalambos Beyers, Nulda Hayes, Richard J Godfrey-Faussett, Peter Trials Study Protocol BACKGROUND: TB and HIV form a deadly synergy in much of the developing world, especially Africa. Interventions to reduce the impact of these diseases at community level are urgently needed. This paper presents the design of a community randomised trial to evaluate the impact of two complex interventions on the prevalence of tuberculosis (TB) in high HIV prevalence settings in Zambia and South Africa. METHODS: The interaction between TB and HIV is reviewed and possible interventions that could reduce the prevalence of TB in HIV-endemic populations are discussed. Two of these interventions are described in detail and the design of a 2 × 2 factorial community randomised trial to test these interventions is presented. The limitations and challenges of the design are identified and discussed. CONCLUSION: There is an urgent need to reduce the prevalence of TB in communities highly affected by HIV. Potential interventions are complex and require innovative trial designs to provide the rigorous evidence needed to inform health policy makers and to ensure that resources are used optimally. TRIAL REGISTRATION: Number: ISRCTN36729271 BioMed Central 2008-11-07 /pmc/articles/PMC2585552/ /pubmed/18992133 http://dx.doi.org/10.1186/1745-6215-9-63 Text en Copyright © 2008 Ayles et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Ayles, Helen M
Sismanidis, Charalambos
Beyers, Nulda
Hayes, Richard J
Godfrey-Faussett, Peter
ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2 × 2 factorial community randomized trial
title ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2 × 2 factorial community randomized trial
title_full ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2 × 2 factorial community randomized trial
title_fullStr ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2 × 2 factorial community randomized trial
title_full_unstemmed ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2 × 2 factorial community randomized trial
title_short ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2 × 2 factorial community randomized trial
title_sort zamstar, the zambia south africa tb and hiv reduction study: design of a 2 × 2 factorial community randomized trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2585552/
https://www.ncbi.nlm.nih.gov/pubmed/18992133
http://dx.doi.org/10.1186/1745-6215-9-63
work_keys_str_mv AT ayleshelenm zamstarthezambiasouthafricatbandhivreductionstudydesignofa22factorialcommunityrandomizedtrial
AT sismanidischaralambos zamstarthezambiasouthafricatbandhivreductionstudydesignofa22factorialcommunityrandomizedtrial
AT beyersnulda zamstarthezambiasouthafricatbandhivreductionstudydesignofa22factorialcommunityrandomizedtrial
AT hayesrichardj zamstarthezambiasouthafricatbandhivreductionstudydesignofa22factorialcommunityrandomizedtrial
AT godfreyfaussettpeter zamstarthezambiasouthafricatbandhivreductionstudydesignofa22factorialcommunityrandomizedtrial